BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND RARA, RAR, 5914, ENSG00000131759, NR1B1
1404 results:

  • 1. PML::rara and GATA2 proteins interact via DNA templates to induce aberrant self-renewal in mouse and human hematopoietic cells.
    Katerndahl CDS; Rogers ORS; Day RB; Xu Z; Helton NM; Ramakrishnan SM; Miller CA; Ley TJ
    Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2317690121. PubMed ID: 38648485
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A Case of Relapsed/Refractory CD56-Positive Acute Promyelocytic leukemia, in Which Complete Molecular Remission Was Achieved Following Combination Therapy with Venetoclax and Azacitidine.
    Sekiguchi Y; Tsutsumi H; Gomyo A; Kudo M; Maseki N; Iizaki Y; Kawamura M; Kobayashi K; Nitta H; Noguchi M; Wakita S; Yamaguchi H; Kobayashi H
    Gan To Kagaku Ryoho; 2024 Mar; 51(3):291-297. PubMed ID: 38494811
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Report of IRF2BP1 as a novel partner of rara in variant acute promyelocytic leukemia.
    Jiang M; Wang X; Yu M; Jiang S; Hong M; Zhou Y; Li F; Liu H; Zhang Z
    Am J Hematol; 2024 May; 99(5):1005-1007. PubMed ID: 38410879
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of a novel fusion gene, rara::ANKRD34C, in acute promyelocytic leukemia.
    Chen Y; Pan M; Chen L; Peng M; Liu Z; Fang Y; Du Y; Yang Y; Xu P
    Ann Hematol; 2024 Apr; 103(4):1181-1185. PubMed ID: 38294534
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Analysis of the clinical characteristics of acute myeloid leukemia related to the treatment of hematological and solid tumors].
    Jiao Y; Jiang YH; Liu B; Mi RH; Bi LJ; Xu QX
    Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):86-95. PubMed ID: 38246784
    [No Abstract]    [Full Text] [Related]  

  • 6. Harnessing intermolecular G-quadruplex-based spatial confinement effect for accelerated activation of CRISPR/Cas12a empowers ultra-sensitive detection of PML/rara fusion genes.
    Wang X; Zheng D; Wang C; Xue D; Wang Q; Xia J
    Anal Chim Acta; 2024 Jan; 1287():342108. PubMed ID: 38182385
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of concurrent STAT3::rara and rara::STAT5b fusions in a variant APL case.
    Tao T; Cen J; Xu C; Chen Y; Cao Y; Gong Y; Zhu M; Chen S; Zhang Q; Yao L
    Mol Carcinog; 2024 Apr; 63(4):558-562. PubMed ID: 38153216
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Venetoclax overcomes resistance to all-trans retinoic acid in a variant acute promyelocytic leukemia with TNRC18::rara fusion.
    Xu J; Li H; Wang Z; Wang M; Li Q; Hang X; Xu J; Ji J; Chen C; Liu Y; Niu T
    Mol Carcinog; 2024 Apr; 63(4):553-557. PubMed ID: 38131515
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Mutations at proximal cysteine residues in PML impair ATO binding by destabilizing the RBCC domain.
    Dubey S; Mishra N; Shelke R; Varma AK
    FEBS J; 2024 Apr; 291(7):1422-1438. PubMed ID: 38129745
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Proteogenomic analysis reveals cytoplasmic sequestration of RUNX1 by the acute myeloid leukemia-initiating CBFB::MYH11 oncofusion protein.
    Day RB; Hickman JA; Xu Z; Katerndahl CD; Ferraro F; Ramakrishnan SM; Erdmann-Gilmore P; Sprung RW; Mi Y; Townsend RR; Miller CA; Ley TJ
    J Clin Invest; 2023 Dec; 134(4):. PubMed ID: 38061017
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia.
    Erkner E; Hentrich T; Schairer R; Fitzel R; Secker-Grob KA; Jeong J; Keppeler H; Korkmaz F; Schulze-Hentrich JM; Lengerke C; Schneidawind D; Schneidawind C
    Oncogene; 2024 Jan; 43(4):281-293. PubMed ID: 38030791
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid leukemia Using Flow Cytometry.
    Lewis JE; Cooper LAD; Jaye DL; Pozdnyakova O
    Mod Pathol; 2024 Jan; 37(1):100373. PubMed ID: 37925056
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Acute promyelocytic leukemia masquerading as myeloid maturation arrest- A Case report.
    Kannan N; Dass J; Viswanathan G; Khokhar P; Aggarwal M
    J Clin Exp Hematop; 2023; 63(3):193-196. PubMed ID: 37766564
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia.
    Li H; Hou J; Fu Y; Zhao Y; Liu J; Guo D; Lei R; Wu Y; Tang L; Fan S
    Ann Hematol; 2023 Dec; 102(12):3357-3367. PubMed ID: 37726492
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Interleukin-37 gene expression is down-regulated in patients with acute myeloid leukemia and shown to be affected by CD14 and HLA-DR immunophenotypes.
    Bashi MA; Ad'hiah AH
    Cytokine; 2023 Nov; 171():156368. PubMed ID: 37716188
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Complex Karyotype Acute Basophilic leukemia with Reactive Mast Cell Hyperplasia.
    Wu Y; Zhang X; Guo H; Guo J; Li R
    Clin Lab; 2023 Sep; 69(9):. PubMed ID: 37702688
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cytogenetically Cryptic Acute Promyelocytic leukemia: A Diagnostic Challenge.
    Mohebnasab M; Li P; Hong B; Dunlap J; Traer E; Fan G; Press RD; Moore SR; Xie W
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685882
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Structural Basis of PML-rara Oncoprotein Targeting by Arsenic Unravels a Cysteine Rheostat Controlling PML Body Assembly and Function.
    Bercier P; Wang QQ; Zang N; Zhang J; Yang C; Maimaitiyiming Y; Abou-Ghali M; Berthier C; Wu C; Niwa-Kawakita M; Dirami T; Geoffroy MC; Ferhi O; Quentin S; Benhenda S; Ogra Y; Gueroui Z; Zhou C; Naranmandura H; de Thé H; Lallemand-Breitenbach V
    Cancer Discov; 2023 Dec; 13(12):2548-2565. PubMed ID: 37655965
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Use of tamibarotene, a potent and selective rarα agonist, in combination with azacitidine in patients with relapsed and refractory AML with
    Stein EM; de Botton S; Cluzeau T; Pigneux A; Liesveld JL; Cook RJ; Rousselot P; Rizzieri DA; Braun T; Roboz GJ; Lebon D; Heiblig M; Baker K; Volkert A; Paul S; Rajagopal N; Roth DA; Kelly M; Peterlin P
    Leuk Lymphoma; 2023 Dec; 64(12):1992-2001. PubMed ID: 37571998
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The lncRNA expression profile signature of leukemia stem cells is altered upon PI3K/mTOR inhibition: an
    Kayabasi C; Gunduz C
    Nucleosides Nucleotides Nucleic Acids; 2024; 43(2):99-115. PubMed ID: 37470414
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 71.